Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Psychotic depression

W Coryell1

  • 1Department of Psychiatry, University of Iowa Hospitals and Clinics, College of Medicine, Iowa City 52242, USA.

The Journal of Clinical Psychiatry
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Psychotic depression, marked by delusions or hallucinations, signifies a severe major depressive disorder with poor outcomes. Combination therapy with antidepressants and antipsychotics, or electroconvulsive therapy, improves recovery rates for this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants.

Molecular psychiatry·2012
Same author

Genome-wide association study of recurrent early-onset major depressive disorder.

Molecular psychiatry·2010
Same author

Novel loci for major depression identified by genome-wide association study of Sequenced Treatment Alternatives to Relieve Depression and meta-analysis of three studies.

Molecular psychiatry·2009
Same author

Genome-wide association study of bipolar disorder in European American and African American individuals.

Molecular psychiatry·2009
Same author

Age transitions in the course of bipolar I disorder.

Psychological medicine·2009
Same author

Does major depressive disorder change with age?

Psychological medicine·2009
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay in the United States.

The Journal of clinical psychiatry·2026
Same journal

Hallucinogen-Psychosis Associations Are Confounded by Baseline Psychiatric History.

The Journal of clinical psychiatry·2026
Same journal

Placebo Effects in Alcohol, Cocaine, and Methamphetamine Use Disorder: A Systematic Review and Meta-Analysis.

The Journal of clinical psychiatry·2026
See all related articles

Area of Science:

  • Neuroscience
  • Psychiatry
  • Clinical Psychology

Background:

  • Major depressive disorder (MDD) with psychotic features represents a severe subtype.
  • Patients with psychotic depression exhibit more severe depressive symptoms and distinct neurobiological markers.
  • These markers include hypothalamic-pituitary-adrenal axis hyperactivity and increased ventricular-to-brain ratios.

Purpose of the Study:

  • To review the clinical characteristics, neurobiological correlates, and treatment outcomes of major depressive disorder with psychotic features.
  • To highlight the long-term significance and prognostic implications of psychotic symptoms in MDD.

Main Methods:

  • Literature review and synthesis of existing research on psychotic depression.
  • Comparison of clinical and neurobiological profiles between psychotic and non-psychotic depression.

Related Experiment Videos

  • Analysis of treatment efficacy for various therapeutic interventions.

    • Main Results:

    • Psychotic depression is associated with more severe individual symptoms, hypothalamic-pituitary-adrenal axis hyperactivity, and increased ventricular-to-brain ratios.
    • Outcomes are poorer in the short and long term, with a high recurrence rate of psychotic features, suggesting lifelong significance.
    • Combination therapy (antidepressants plus antipsychotics) leads to more rapid recovery than antidepressant monotherapy; electroconvulsive therapy is highly effective.

    Conclusions:

    • Psychotic depression is a severe subtype of MDD with significant long-term implications and poor prognosis.
    • Combined pharmacological treatments and electroconvulsive therapy are effective interventions.
    • The role of combination therapy in prophylaxis remains undetermined.